Effect of gamma-oryzanol on the bioaccessibility and synthesis of cholesterol

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 49-56

  Makynen K ^a   Chitchumroonchokchai, C ^a,b   Adisakwattana, S ^a   Failla, M L ^a   Ariyapitipun, T ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Bioaccessibility; Caco 2 cells; Cholesterol; HMG CoA reductase; Oryzanol

Indexed keywords

CHOLESTEROL; GAMMA ORYZANOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL STRAIN CACO 2; CONTROLLED STUDY; DIGESTION; DRUG EFFECT; IN VITRO STUDY; INTESTINE CELL; MALE; MICELLE; NONHUMAN; RAT; REVIEW; SYNTHESIS;

ANIMALS; CACO-2 CELLS; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPOLIPIDEMIC AGENTS; INTESTINAL ABSORPTION; LIVER; MICELLES; ORYZA SATIVA; PHENYLPROPIONATES; PLANT OILS; RATS;

EID: 84859814690     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. XU Z, GODBER JS. Purification and identification of components of gamma-oryzanol in rice bran oil. J Agric Food Chem 1999;47:2724-2728. (Pubitemid 29396347)
2. ROGERS EJ, RICE SM, NICOLOSI RJ, CARPENTER DR, MC-CLELLAND CA, ROMANCZYK J L J. Identification and quantitation of gamma-oryzanol components and simultaneous assessment of tocols in rice bran oil. J Am Oil Chem Soc 1993;70:301-307.
3. DIACK M, SAKSKA M. Separation of vitamin e and gamma-oryzanols from rice bran by normalphase chromatography. J Am Oil Chem Soc 1994;71:1211-1217.
4. IQBAL S, BHANGER MI, ANWAR F. Antioxidant properties and components of some commercial available varieties of rice bran in Pakistan. Food Chem 2005;93:265-272. (Pubitemid 40724512)
5. RUKMINI C, RAGHURAM TC. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J Am Coll Nutr 1991;10:593-601.
6. SEETHARAMAIAH GS, CHANDRASEKHARA N. Studies on hypocholesterolemic activity of oryzanol in rats. Nutr Rep Int 1988;38:927-932.
7. RONG N, AUSMAN LM, NICOLOSI RJ. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids 1997;32:303-309. (Pubitemid 27131763)
8. FUKUSHIMA M, FUJII S, YOSHIMURA Y, ENDO T, NAKANO M. Effect of rice bran on intraintestinal fermentation and cholesterol metabolism in cecectomized rats. Nutr Res 1999;19:235-245. (Pubitemid 29131649)
9. BERGER A, REIN D, SCHAFER A, MONNARD I, GREMAUD G, LAMBELET P, BERTOLI C. Similar cholesterol-lowering properties of rice bran oil, with varied gammaoryzanol, in mildly hypercholesterolemic men. Eur J Nutr 2005;44:163-173. (Pubitemid 40585515)
10. HA T-Y, HAN S, KIM I-H, LEE H-Y, KIM H-K. Bioactive components in rice bran oil improve lipid profiles in rats fed a high-cholesterol diet. Nutr Res 2005;25:597-606. (Pubitemid 41133663)
11. MOST MM, TULLEY R, MORALES S, LEFEVRE M. Rice bran oil, not fiber, lowers cholesterol in humans. Am J Clin Nutr 2005;81:64-68. (Pubitemid 43073376)
12. SEETHARAMAIAH GS, CHANDRASEKHARA N. Studies on hypocholesterolemic activity of rice bran oil. Atherosclerosis 1989;78:219-223. (Pubitemid 19195492)
13. SHINOMIYA M, MORISAKI N, MATSUOKA N, IZUMI S, SAITO Y, KUMAGAI A, MITANI K, MORITA S. Effects of gammaoryzanol on lipid metabolism in rats fed high-cholesterol diet. Tohoku J Exp Med 1983;141:191-197. (Pubitemid 14224953)
14. SASAKI J, TAKADA Y, HANDA K, KUSUDA M, TANABE Y, MATSUNAGA A, ARAKAWA K. Effects of gammaoryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin Ther 1990;12:263-268. (Pubitemid 20208893)
15. YOSHINO G, KAZUMI T, AMANO M, TAKEIWA M, YAMASAKI Y, TAKASHIMA S, et al. Effects of gamma-oryzanol on hyperlipidemic subjects. Curr Ther Res 1989;45:543-552. (Pubitemid 19114034)
16. IKEDA I, TANAKA K, SUGANO M, VAHOUNY G V, GALLO LL. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res 1988;29:1573-1582. (Pubitemid 19030525)
17. VAUGHAN CJ, GOTTO AM. Update on Statins: 2003. Circulation 2004;110:886-892. (Pubitemid 39096019)
18. CHITCHUMROONCHOKCHAI C, SCHWARTZ SJ, FAILLA ML. Assessment of lutein bioavailability from meals and a supplement using simulated digestion and Caco-2 human intestinal cells. J Nutr 2004;134:2280-2286. (Pubitemid 39201597)
19. GARRETT DA, FAILLA ML, SARAMA RJ. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J Agric Food Chem 1999;47:4301-4309. (Pubitemid 29506240)
20. THAKKAR S, MAZIYA DIXON B, DIXON A G O, FAILLA ML. β-carotene micellarization during in vitro digestion and uptake by Caco-2 cells is directly proportional to β-carotene content in different genotypes of cassava. J Nutr 2007;137:2229-2233. (Pubitemid 47529582)
21. KIM YS, JUNG EA, SHIN JE, CHANG JC, YANG HK, KIM NJ, CHO KH, BAE HS, MOON SK, KIM DH. Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull 2002;25:1442-1445.
22. ALTMANN SW, DAVIS-JR. HR, Zhu L-J, Yao X, Hoos LM, Tetzloff G, Iyer S P, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-1204. (Pubitemid 38233587)
23. DAVIS H R J, ZHU L-J, HOOS LM, TETZLOFF G, MAGUIRE M, LIU J, YAO X, IYER S P, LAM MH, LUND EG, DETMERS PA, GRAZIANO M P, ALTMANN SW. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004;279:33586-33592. (Pubitemid 39063007)
24. GRAF GA, LI W P, GERARD RD, GELISSEN I, WHITE A, COHEN JC, HOBBS HH. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002;110:659-669. (Pubitemid 34988790)
25. PLAT J, MENSINK R P. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J 2002;16:1248-1253. (Pubitemid 34815413)
26. FUJIWARA S, SAKURAI S, SUGIMOTO I, AWATA N. Absorption and metabolism of gamma-oryzanol in rats. Chem Pharm Bull 1983;31:645-652.
27. UMEHARA K, SHIMOKAWA Y, MIYAMOTO G. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes. Biol Pharm Bull 2004;27:1151-1153. (Pubitemid 41701779)
28. CICERO A F, GADDI A. Rice bran oil and gammaoryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 2001;15:277-289. (Pubitemid 32613093)
29. CHEN CW, CHENG HH. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr 2006;136:1472-1476.
30. NATIONAL CHOLESTEROL EDUCATION PROGRAM. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143-3421.